Vivani sets Oct 8 record date for Cortigent spin-off; Cortigent to trade as CRGT

Vivani Medical, Inc.

Record date for Cortigent spin-off is October 8, 2025; distribution date and ratio to be announced later.
Spin-off expected to complete by late-2025; Cortigent will trade on Nasdaq under ticker CRGT.
Cortigent develops brain implants (Orion vision system, stroke recovery device); has completed 6-year feasibility study.
Post spin-off, Vivani focuses on ultra long-acting GLP-1 implants for weight loss and type 2 diabetes.
Management teams will each focus on their respective strategies; Cortigent CEO Jonathan Adams to stay on.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.